InflaRx (IFRX) Enterprise Value (2022 - 2025)
Historic Enterprise Value for InflaRx (IFRX) over the last 4 years, with Q3 2025 value amounting to -$44654.6 billion.
- InflaRx's Enterprise Value fell 2833.58% to -$44654.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$44654.6 billion, marking a year-over-year decrease of 2833.58%. This contributed to the annual value of -$37299.9 billion for FY2024, which is 3840286598.14% down from last year.
- Latest data reveals that InflaRx reported Enterprise Value of -$44654.6 billion as of Q3 2025, which was down 2833.58% from -$20.8 million recorded in Q2 2025.
- InflaRx's Enterprise Value's 5-year high stood at -$20.8 million during Q2 2025, with a 5-year trough of -$44654.6 billion in Q3 2025.
- Its 4-year average for Enterprise Value is -$7751.8 billion, with a median of -$97.1 million in 2023.
- In the last 5 years, InflaRx's Enterprise Value crashed by 3791524769.67% in 2024 and then soared by 7184.57% in 2025.
- Over the past 4 years, InflaRx's Enterprise Value (Quarter) stood at -$92.9 million in 2022, then fell by 4.55% to -$97.1 million in 2023, then crashed by 37915247.7% to -$36826.3 billion in 2024, then dropped by 21.26% to -$44654.6 billion in 2025.
- Its Enterprise Value was -$44654.6 billion in Q3 2025, compared to -$20.8 million in Q2 2025 and -$38.9 million in Q1 2025.